01 1Zhejiang Starry Pharmaceutical Co., Ltd
01 1IODIXANOL USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-09-15
Pay. Date : 2022-07-27
DMF Number : 36468
Submission : 2022-01-14
Status : Active
Type : II
20
Zhejiang Starry Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IODIXANOL USP, with a corresponding US DMF Number 36468.
Remarkably, this DMF maintains an Active status since its submission on January 14, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 15, 2022, and payment made on July 27, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
